Literature DB >> 8029625

Results of oral steroid treatment in nasal polyposis.

C van Camp1, P A Clement.   

Abstract

Twenty-five patients with massive nasal polyposis were treated during four days with 60 mg oral prednisolone (Deltacortril) followed by a progressive reduction of the dose (minus 5 mg per day). Therapeutic efficacy was evaluated by means of symptoms, anterior rhinoscopy, and a CT scan of the sinuses before and at the first visit after the treatment. Seventy-two per cent of the patients showed subjective improvement due to the involution of polyps in the nasal cavity. However, on CT of the paranasal sinuses only 52% showed a clear improvement. In general, the frontal and sphenoid sinuses were more likely to clear up completely than were the ethmoidal and maxillary sinuses. Therapeutic efficacy seemed to be better in the group of ASA-intolerant patients and worse in the allergic group. The "intrinsic" group showed an equal distribution of good results. Also, the presence of eosinophils in polyps played no role in the therapeutic outcome. We found a strong tendency of recurrence within five months after successful oral steroid therapy. On the other hand, pre-operative systemic steroid therapy considerably facilitated the surgical procedure. Keeping in mind the side effects of systemic steroid therapy, this treatment should be mainly reserved for cases in which surgery is planned.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8029625

Source DB:  PubMed          Journal:  Rhinology        ISSN: 0300-0729            Impact factor:   3.681


  21 in total

1.  [Rhinosinusitis guidelines--unabridged version: S2 guidelines from the German Society of Otorhinolaryngology, Head and Neck Surgery].

Authors:  B A Stuck; C Bachert; P Federspil; W Hosemann; L Klimek; R Mösges; O Pfaar; C Rudack; H Sitter; M Wagenmann; R Weber; K Hörmann
Journal:  HNO       Date:  2012-02       Impact factor: 1.284

2.  [Treatment of olfactory disorders].

Authors:  T Hummel; B A Stuck
Journal:  HNO       Date:  2010-07       Impact factor: 1.284

Review 3.  Surgical versus medical interventions in CRS and nasal polyps: comparative evidence between medical and surgical efficacy.

Authors:  Osama Dessouky; Claire Hopkins
Journal:  Curr Allergy Asthma Rep       Date:  2015-11       Impact factor: 4.806

Review 4.  Rhinosinusitis diagnosis and management for the clinician: a synopsis of recent consensus guidelines.

Authors:  Eli O Meltzer; Daniel L Hamilos
Journal:  Mayo Clin Proc       Date:  2011-04-13       Impact factor: 7.616

5.  [Rhinosinusitis guidelines of the German Society for Otorhinolaryngology, Head and Neck Surgery].

Authors:  B A Stuck; C Bachert; P Federspil; W Hosemann; L Klimek; R Mösges; O Pfaar; C Rudack; H Sitter; M Wagenmann; K Hörmann
Journal:  HNO       Date:  2007-10       Impact factor: 1.284

6.  Effects of lysine-acetylsalicylate (LAS) treatment in nasal polyposis: two controlled long term prospective follow up studies.

Authors:  E Nucera; D Schiavino; A Milani; M Del Ninno; C Misuraca; A Buonomo; C D'Ambrosio; G Paludetti; G Patriarca
Journal:  Thorax       Date:  2000-10       Impact factor: 9.139

7.  Topical furosemide versus oral steroid in preoperative management of nasal polyposis.

Authors:  Bozidar Kroflic; Andrej Coer; Tomislav Baudoin; Livije Kalogjera
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-05-10       Impact factor: 2.503

Review 8.  [Olfactory dysfunction due to nasal sinus disease. Causes, consequences, epidemiology, and therapy].

Authors:  T Hummel; K B Hüttenbrink
Journal:  HNO       Date:  2005-05       Impact factor: 1.284

Review 9.  Sinus surgery: indications and techniques.

Authors:  Amber Luong; Bradley F Marple
Journal:  Clin Rev Allergy Immunol       Date:  2006-06       Impact factor: 8.667

10.  Comparison of the effect of endoscopic sinus surgery versus medical therapy on olfaction in nasal polyposis.

Authors:  Mohammad Hossein Baradaranfar; Zeynab Sadat Ahmadi; Mohammad Hossein Dadgarnia; Mohammad Hossein Bemanian; Saeid Atighechi; Ghasem Karimi; Abolhasan Halvani; Nasim Behniafard; Amin Baradaranfar; Tohid Emami Meybodi
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-05-23       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.